-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

A New Treatment Option for Patients with Acute Myeloid Leukemia

Sponsor: Bristol Myers Squibb
Program: Product Theaters
Saturday, December 5, 2020: 11:00 AM-12:00 PM

Michelle Little, PhD

Bristol Myers Squibb, Princeton, NJ

See more of: Product Theaters